Yin Liu Selected Research

Adapalene (Differin)

6/2010	Adapalene 0.1% lotion in the treatment of acne vulgaris: results from two placebo-controlled, multicenter, randomized double-blind, clinical studies.
8/2009	A North American study of adapalene-benzoyl peroxide combination gel in the treatment of acne.
6/2008	Long-term safety and efficacy study of adapalene 0.3% gel.
11/2007	Adapalene-benzoyl peroxide, a fixed-dose combination for the treatment of acne vulgaris: results of a multicenter, randomized double-blind, controlled study.
9/2007	Long-term safety and efficacy of a unique fixed-dose combination gel of adapalene 0.1% and benzoyl peroxide 2.5% for the treatment of acne vulgaris.
2/2006	Adapalene gel 0.3% for the treatment of acne vulgaris: a multicenter, randomized, double-blind, controlled, phase III trial.
8/2005	The efficacy and safety of adapalene gel 0.3% in the treatment of acne vulgaris: A randomized, multicenter, investigator-blinded, controlled comparison study versus adapalene gel 0.1% and vehicle.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yin Liu Research Topics

Disease

69	Neoplasms (Cancer) 04/2022 - 12/2003
27	Breast Neoplasms (Breast Cancer) 01/2022 - 05/2005
17	Neoplasm Metastasis (Metastasis) 03/2022 - 12/2003
17	Infections 01/2020 - 11/2003
13	Prostatic Neoplasms (Prostate Cancer) 01/2021 - 01/2006
12	Myocardial Infarction 02/2022 - 10/2013
12	Carcinogenesis 11/2020 - 01/2013
10	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 05/2015
9	Inflammation (Inflammations) 06/2022 - 08/2008
9	ST Elevation Myocardial Infarction 01/2022 - 01/2020
8	Dementia (Dementias) 11/2022 - 07/2015
8	Thrombosis (Thrombus) 01/2022 - 01/2012
7	Virus Diseases (Viral Diseases) 01/2022 - 04/2007
7	Non-ST Elevated Myocardial Infarction 01/2022 - 01/2021
7	Nasopharyngeal Carcinoma 01/2017 - 06/2003
7	Acne Vulgaris 06/2010 - 08/2005
6	Body Weight (Weight, Body) 01/2022 - 07/2004
6	Neuroblastoma 01/2018 - 02/2013
5	Type 2 Diabetes Mellitus (MODY) 06/2022 - 01/2015
5	Triple Negative Breast Neoplasms 01/2022 - 01/2013
5	Heart Failure 01/2022 - 02/2016
5	Obesity 01/2021 - 08/2004
5	Morphine Dependence 03/2012 - 10/2005
4	Adenocarcinoma 07/2022 - 01/2017
4	Ischemia 05/2022 - 08/2014
4	Acute Coronary Syndrome 01/2022 - 02/2011
4	Stroke (Strokes) 02/2021 - 01/2016
4	Hypertrophy 01/2021 - 02/2007
4	Melanoma (Melanoma, Malignant) 10/2020 - 07/2010
4	Lung Neoplasms (Lung Cancer) 01/2020 - 12/2011
4	AIDS-Related Complex (ARC) 11/2018 - 01/2011
4	Opioid-Related Disorders (Opiate Addiction) 03/2012 - 10/2005
3	Hyperglycemia 07/2022 - 05/2011
3	Guillain-Barre Syndrome 02/2022 - 01/2018
3	Ischemic Stroke 02/2022 - 08/2014
3	Pathologic Constriction (Stenosis) 01/2022 - 02/2011
3	Coronary Artery Disease (Coronary Atherosclerosis) 01/2022 - 06/2011
3	Insulin Resistance 01/2022 - 12/2019
3	Hypertension (High Blood Pressure) 01/2022 - 06/2009
3	Infarction (Infarctions) 01/2022 - 09/2014
3	Pain (Aches) 01/2022 - 05/2008
3	Coronary Disease (Coronary Heart Disease) 05/2021 - 02/2017
3	Tuberculosis (Tuberculoses) 03/2021 - 01/2019
3	Disease Progression 01/2021 - 09/2016
3	Experimental Autoimmune Neuritis 11/2020 - 01/2017
3	Stomach Neoplasms (Stomach Cancer) 06/2020 - 01/2018

Drug/Important Bio-Agent (IBA)

29	Proteins (Proteins, Gene)FDA Link 01/2022 - 06/2005
21	Pharmaceutical PreparationsIBA 07/2022 - 05/2011
19	Biomarkers (Surrogate Marker)IBA 07/2022 - 11/2010
11	Transcription Factors (Transcription Factor)IBA 01/2020 - 11/2006
9	omega-Chloroacetophenone (Mace)IBA 01/2022 - 01/2020
8	MicroRNAs (MicroRNA)IBA 11/2021 - 05/2009
8	LigandsIBA 11/2020 - 10/2005
7	Peptides (Polypeptides)IBA 04/2022 - 05/2008
7	Long Noncoding RNAIBA 01/2022 - 01/2015
7	Messenger RNA (mRNA)IBA 11/2020 - 11/2003
7	AgmatineIBA 03/2012 - 05/2005
7	Adapalene (Differin)FDA LinkGeneric 06/2010 - 08/2005
6	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 11/2003
6	Small Interfering RNA (siRNA)IBA 01/2019 - 02/2007
5	CytokinesIBA 04/2022 - 12/2009
5	Hormones (Hormone)IBA 01/2021 - 06/2011
5	Biological ProductsIBA 11/2020 - 05/2013
5	NF-kappa B (NF-kB)IBA 01/2018 - 08/2008
5	AndrogensIBA 06/2011 - 01/2006
5	Androgen Receptors (Androgen Receptor)IBA 03/2010 - 01/2006
5	alpha-Mannosidase (LAMAN)IBA 12/2008 - 12/2003
4	Insulin (Novolin)FDA Link 06/2022 - 01/2015
4	Estrogens (Estrogen)FDA Link 02/2022 - 08/2008
4	Glucose (Dextrose)FDA LinkGeneric 02/2021 - 08/2016
4	InterferonsIBA 01/2021 - 06/2013
4	Interleukin-6 (Interleukin 6)IBA 11/2020 - 12/2009
4	MagnesiumIBA 11/2018 - 01/2011
4	Monoamine Oxidase (MAO)IBA 11/2018 - 01/2011
4	Reactive Oxygen Species (Oxygen Radicals)IBA 03/2018 - 08/2010
4	Phospholipases (Phospholipase)IBA 07/2012 - 11/2010
4	Mitogen-Activated Protein KinasesIBA 03/2012 - 11/2006
3	Hydrocortisone (Cortisol)FDA LinkGeneric 11/2022 - 05/2016
3	Blood Glucose (Blood Sugar)IBA 07/2022 - 01/2018
3	RNA (Ribonucleic Acid)IBA 03/2022 - 01/2012
3	Therapeutic UsesIBA 03/2022 - 10/2007
3	oxidized low density lipoproteinIBA 05/2021 - 01/2021
3	MetalsIBA 05/2021 - 05/2015
3	Paclitaxel (Taxol)FDA LinkGeneric 01/2021 - 03/2018
3	Estrogen ReceptorsIBA 01/2021 - 06/2008
3	ChemokinesIBA 01/2021 - 01/2018
3	CateninsIBA 11/2020 - 06/2019
3	Cadherins (E-Cadherin)IBA 11/2020 - 12/2003

Therapy/Procedure

31	Therapeutics 04/2022 - 01/2006
13	Percutaneous Coronary Intervention 02/2022 - 05/2015
11	Stents 01/2022 - 02/2011
9	Neoadjuvant Therapy 04/2021 - 11/2013
6	Drug Therapy (Chemotherapy) 03/2022 - 01/2015
4	Radiotherapy 03/2022 - 02/2016
4	Aftercare (After-Treatment) 03/2022 - 01/2018
3	Immunotherapy 03/2022 - 10/2016
3	Conservative Treatment 01/2022 - 05/2012
3	Transplantation 01/2021 - 03/2013
3	Drug-Eluting Stents 01/2021 - 05/2015
3	Precision Medicine 01/2021 - 12/2015